Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADRC therapy for post-prostatectomy stress urinary incontinence
jRCTb070200022Suspended
- Start
- Dec 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous adipose-derived stem/stromal cells in stress urinary incontinence (SUI). Primary endpoint: Safety through 52 weeks after cell transplantation. Started Dec 2020; status: suspended.
02
Drugs
autologous adipose-derived stem/stromal cells
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on jRCTb070200022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb070200022.